Quantum BioPharma’s unbuzzd™ Shows Promising Results in Reducing Alcohol Intoxication and Hangover Symptoms

Quantum BioPharma (NASDAQ: QNTM) announced compelling results from a clinical trial evaluating its dietary supplement, unbuzzd. The double-blind, randomized, placebo-controlled study demonstrated that unbuzzd significantly accelerates alcohol metabolism, lowers blood alcohol concentration (BAC), and reduces symptoms of intoxication and hangovers.

Participants in the trial, aged 21 to 43, experienced a rapid reduction in BAC—more than 40% faster than those given a placebo. These effects were noticeable within 30 minutes of consuming the supplement and sustained over a four-hour period. In addition to faster alcohol metabolism, participants reported improved alertness and cognitive performance, with fewer errors and reduced mental fatigue compared to the placebo group.

Physiological benefits were also evident. unbuzzd stabilized heart rate and blood pressure, counteracting typical alcohol-induced fluctuations. Hangover symptoms, particularly headaches, were notably reduced by 67% at the four-hour mark and continued to decrease eight hours post-consumption.

“We are thrilled to see such significant and meaningful outcomes in this clinical study,” said Dr. Andrzej Chruscinski, Vice President of Clinical and Scientific Affairs at Quantum BioPharma. “The results confirm unbuzzd™’s exceptional performance in reducing the acute effects of alcohol intoxication.”

Importantly, unbuzzd was well-tolerated by all participants, with no reported side effects, reinforcing its safety profile.

Zeeshan Saeed, CEO of Quantum BioPharma, emphasized the supplement’s role in promoting responsible alcohol consumption. “This clinical trial shows that unbuzzd is an important addition to the safe and responsible consumption of alcohol. Consumers now have the benefit of knowing that unbuzzd can reduce alcohol intoxication, speed the reduction of blood alcohol concentration, restore mental alertness, and help them avoid the worst symptoms of a hangover,” Saeed said.

The study’s promising results position unbuzzd as a breakthrough product in the wellness and dietary supplement market, offering consumers an innovative solution to mitigate the effects of alcohol consumption.

You might like this article: GH Research Achieves Breakthrough with Ultra-Rapid Antidepressant GH001 in Phase 2b Trial